| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | -14.4% |
| SG&A Expense | $4.4M | -1.9% |
| Operating Income | -$8.0M | +7.9% |
| Income Tax | $0 | — |
| Net Income | -$15.0M | — |
| EPS (Basic) | -$87.68 | — |
| EPS (Diluted) | -$87.68 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -45.8% |
| Current Assets | $6.6M | -46.0% |
| Total Assets | $6.6M | -45.8% |
| Current Liabilities | $1.9M | -65.6% |
| Total Liabilities | $1.9M | -65.6% |
| Stockholders' Equity | $4.7M | -29.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.3M | -151.4% |
| Capital Expenditures | $19K | — |
| Investing Cash Flow | -$19K | — |
| Financing Cash Flow | $12.8M | -8.4% |
| Free Cash Flow | -$18.3M | — |